MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer
Cell Reports · 2025-12 · 44 (12) · 116604
DOI: 10.1016/j.celrep.2025.116604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-12. Verfasst von Fabio Giuntini und 26 weiteren Autor:innen. Beteiligte Einrichtung: Models of Cancer Therapies Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, DNA Damage, Proto-Oncogene Proteins c-myc, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Government of Catalonia, Agència de Gestió d'Ajuts Universitaris i de Recerca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Models of Cancer Therapies Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Models of Cancer Therapies Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain.
- Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Förderung
- European Research Council
- Government of Catalonia
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Carlos III Health Institute
- Gobierno de España Ministerio de Ciencia e Innovación
- European Commission
- Fundación Cellex
- H2020 European Research Council
Zitieren
APA
Giuntini, F., González-Larreategui, Í., Herencia-Ropero, A., Casacuberta-Serra, S., Zacarías-Fluck, M. F., Arnal, M., Pedretti, F., Martínez-Martín, S., Thabussot, H., Cano, V. C., Grueso, J., Foradada, L., Serrano, E., López-Estévez, S., Rodriguez, O., Guzman, M., Rodriguez-Hernandez, A., Brasó-Maristany, F., Llop-Guevara, A., …, & Soucek, L. (2025). MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer. Cell Reports, 44(12), 116604. https://doi.org/10.1016/j.celrep.2025.116604
Vancouver
Giuntini F, González-Larreategui Í, Herencia-Ropero A, Casacuberta-Serra S, Zacarías-Fluck MF, Arnal M, et al. MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer. Cell Reports. 2025;44(12):116604. doi:10.1016/j.celrep.2025.116604
BibTeX
@article{Giuntini2025,
author = {Giuntini, Fabio and González-Larreategui, Íñigo and Herencia-Ropero, Andrea and Casacuberta-Serra, Silvia and Zacarías-Fluck, Mariano F and Arnal, Magdalena and Pedretti, Flaminia and Martínez-Martín, Sandra and Thabussot, Hugo and Cano, Virginia Castillo and Grueso, Judit and Foradada, Laia and Serrano, Erika and López-Estévez, Sergio and Rodriguez, Olga and Guzman, Marta and Rodriguez-Hernandez, Adela and Brasó-Maristany, Fara and Llop-Guevara, Alba and Balmaña, Judith and Nonell, Lara and Prat, Aleix and Serra, Violeta and Beaulieu, Marie-Eve and Whitfield, Jonathan R and Massó-Vallés, Daniel and Soucek, Laura},
title = {MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {12},
pages = {116604},
doi = {10.1016/j.celrep.2025.116604}
}
EUVIMED